Injective (INJ) rallied 27% in 24 hours on Oct. 16, outperforming NEAR’s 14.54% gain and Sei’s 11.36% rise, according to CoinGecko data. The surge coincides with a new filing by 21Shares for an ETF that would hold INJ directly. The proposed product distinguishes itself by potentially staking a portion of its holdings, offering investors yield exposure alongside spot price appreciation. This development marks a significant step toward institutional access for the Injective ecosystem within the regulated ETF market.